ConductScience.org, home

Paper328032

Diflunisal: a review of pharmacokinetic and pharmacodynamic properties, drug interactions, and special tolerability studies in humans.

Tempero KF and 2 others. Br J Clin Pharmacol, 1977. Cited by 71 papers, by iCite.

Cite this record

ConductScience Library. Diflunisal: a review of pharmacokinetic and pharmacodynamic properties, drug interactions, and special tolerability studies in humans. Papers, record 328032. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/328032

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Diflunisal: a review of pharmacokinetic and pharmacodynamic properties, drug interactions, and special tolerability studies in humans.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1977
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
71
iCite
Relative citation ratio, by iCite
3.32
iCite
Revised in PubMed
2019-05-09
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tempero KFK F
2Cirillo VJV J
3Steelman SLS L

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Inflammatory Agents, Non-SteroidalMajor topic
SalicylatesMajor topic
Anticoagulants
Benzothiadiazines
Blood Glucose
Blood Platelets
Diuretics
Drug Interactions
Fluorobenzenes
Gastrointestinal Hemorrhage
Hearing Disorders
Humans
Hypoglycemic Agents
Kinetics
Male
Prostaglandins
Sodium Chloride Symporter Inhibitors
Time Factors
Uric Acid

Source PubMed

Download CSV of topics

References9

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
113673086Study of the paradoxical effects of salicylate in low, intermediate and high dosage on the renal mechanisms for excretion of urate in man.J Clin Invest1959https://conductscience.org/library/papers/13673086PubMed
214329630SALICYLATE OTOTOXICITY: A CLINICAL STUDY.N Engl J Med1965https://conductscience.org/library/papers/14329630PubMed
313666386Reappraisal of the hypoglycemic action of acetylsalicylate.Metabolism1959https://conductscience.org/library/papers/13666386PubMed
44576885Nonsteroid anti-inflammatory agents.Annu Rev Pharmacol1973https://conductscience.org/library/papers/4576885PubMed
51220Physiological disposition and metabolism of 5-(2',4'-difluorophenyl)salicyclic acid, a new salicylate.Drug Metab Dispos1975https://conductscience.org/library/papers/1220PubMed
64521806Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation.Proc Natl Acad Sci U S A1974https://conductscience.org/library/papers/4521806PubMed
74638751Inhibition of prostaglandin synthesis in man.Biochem Biophys Res Commun1972https://conductscience.org/library/papers/4638751PubMed
85455635Effects of large and small doses of hydrochlorothiazide in hypertensive patients.Clin Pharmacol Ther1970https://conductscience.org/library/papers/5455635PubMed
91059088Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.Proc Natl Acad Sci U S A1975https://conductscience.org/library/papers/1059088PubMed

Download CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 71 citations.

PMIDTitleJournalYearIn PapersSource
41287359Salicylic acid: a key natural foundation for next-generation plant defense stimulators.Pest Manag Sci2026https://conductscience.org/library/papers/41287359PubMed
36444793Characterising diflunisal as a transthyretin kinetic stabilizer at relevant concentrations in human plasma using subunit exchange.Amyloid2023https://conductscience.org/library/papers/36444793PubMed
35453279Discovery of MurA Inhibitors as Novel Antimicrobials through an Integrated Computational and Experimental Approach.Antibiotics (Basel)2022https://conductscience.org/library/papers/35453279PubMed
32658475The Structural Basis for Nonsteroidal Anti-Inflammatory Drug Inhibition of Human Dihydrofolate Reductase.J Med Chem2020https://conductscience.org/library/papers/32658475PubMed
25790235Ligand binding to the FA3-FA4 cleft inhibits the esterase-like activity of human serum albumin.PLoS One2015https://conductscience.org/library/papers/25790235PubMed
20393958Single dose oral diflunisal for acute postoperative pain in adults.Cochrane Database Syst Rev2010https://conductscience.org/library/papers/20393958PubMed
18415402[Reduced postoperative opioid requirement with perioperative administration of naproxen. A randomized study in 86 patients with intravenous on-demand analgesia after orthopaedic surgery.].Schmerz1993https://conductscience.org/library/papers/18415402PubMed
8397891Ototoxicity associated with salicylates. A brief review.Drug Saf1993https://conductscience.org/library/papers/8397891PubMed
7426277Failure of alkaline diuresis to enhance diflunisal elimination.Br J Clin Pharmacol1980https://conductscience.org/library/papers/7426277PubMed
7295473The effect of diflunisal on hyaluronic acid production by 'activated' human synovial fibroblasts.Br J Clin Pharmacol1981https://conductscience.org/library/papers/7295473PubMed
7211578Bio-distribution in rats of some salicylates with low gastric ulcerogenicity.Agents Actions1980https://conductscience.org/library/papers/7211578PubMed
7021122Piroxicam: a review of its pharmacological properties and therapeutic efficacy.Drugs1981https://conductscience.org/library/papers/7021122PubMed
6988202Diflunisal: a review of its pharmacological properties and therapeutic use in pain and musculoskeletal strains and sprains and pain in osteoarthritis.Drugs1980https://conductscience.org/library/papers/6988202PubMed
6581036Diflunisal protects human gastric mucosa against damage by indomethacin.Dig Dis Sci1983https://conductscience.org/library/papers/6581036PubMed
6386426Piroxicam. A reappraisal of its pharmacology and therapeutic efficacy.Drugs1984https://conductscience.org/library/papers/6386426PubMed
3549104The pharmacokinetics of non-steroidal anti-inflammatory drugs in the elderly.Clin Pharmacokinet1987https://conductscience.org/library/papers/3549104PubMed
3301150Protein binding as a primary determinant of the clinical pharmacokinetic properties of non-steroidal anti-inflammatory drugs.Clin Pharmacokinet1987https://conductscience.org/library/papers/3301150PubMed
3203058Effect of dose on the glucuronidation and sulphation kinetics of diflunisal in man: single dose studies.Br J Clin Pharmacol1988https://conductscience.org/library/papers/3203058PubMed
2199127Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.Clin Pharmacokinet1990https://conductscience.org/library/papers/2199127PubMed
1794015The problems and pitfalls of NSAID therapy in the elderly (Part II).Drugs Aging1991https://conductscience.org/library/papers/1794015PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/328032

GET https://conductscience.org/api/papers/v1/328032/authors